
    
      to determine healing rates following ultrasound-guided foam sclerotherapy (UGFS) of
      superficial venous reflux (SVR) in patients with open (clinical,etiologic, anatomic and
      pathophysiologic (CEAP) classification, C6) chronic venous ulceration ( CVU) in a randomised
      clinical trial of foam sclerotherapy for patients with venous ulcer
    
  